Tremtelectogene Empogeditemcel

Approval Year

Substance Class	Structurally Diverse Created by `admin` on `Wed Apr 02 12:12:44 GMT 2025` Edited by `admin` on `Wed Apr 02 12:12:44 GMT 2025`
Source Materials Class	ORGANISM
Source Materials Type	ALLOGENIC HUMAN
Source Materials Parent	`G0T704E6Z3` HOMO SAPIENS WHOLE
Part	blood
Fraction Name	cd34+ enriched hematopoietic stem/progenitor cell from hla matched donor
Record UNII	CT5FM8JN3S
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Tremtelectogene Empogeditemcel

Code

English

allogeneic human CD34 + hematopoietic stem and progenitor cells (HSPC) obtained from peripheral blood by leukapheresis from human leukocyte antigen (HLA)-matched healthy donors, genetically modified ex vivo by CRISPR/Cas9 (clustered regularly interspaced

Preferred Name

English

tremtelectogene empogeditemcel [INN]

Common Name

English

Code System Code Type Description

SMS_ID

300000049566

Created by admin on Wed Apr 02 12:12:44 GMT 2025 , Edited by admin on Wed Apr 02 12:12:44 GMT 2025

PRIMARY

INN

12263

Created by admin on Wed Apr 02 12:12:44 GMT 2025 , Edited by admin on Wed Apr 02 12:12:44 GMT 2025

PRIMARY

FDA UNII

CT5FM8JN3S

Created by admin on Wed Apr 02 12:12:44 GMT 2025 , Edited by admin on Wed Apr 02 12:12:44 GMT 2025

PRIMARY

NCI_THESAURUS

C180524

Created by admin on Wed Apr 02 12:12:44 GMT 2025 , Edited by admin on Wed Apr 02 12:12:44 GMT 2025

PRIMARY

Related Record Type Details


					CT5FM8JN3S

Tremtelectogene Empogeditemcel

ACTIVE MOIETY

Comments:

VOR33 will be infused into patients with acute myeloid leukemia (AML) undergoing hematopoietic cell transplant who are known to be at high-risk for leukemia relapse and mortality post transplantation.

Amount: